These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 1703823

  • 1. [Inhibitor hemophilia A--diagnostic and therapeutic significance of controlled substitutions with factor VIII].
    Weippert M, Anders O, Schmidt M, Roewer J.
    Beitr Infusionsther; 1990; 26():174-8. PubMed ID: 1703823
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Suppression of factor VIII inhibitor in children with hemophilia A].
    Zenz W, Muntean W.
    Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
    [Abstract] [Full Text] [Related]

  • 4. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
    de Biasi R, Rocino A, Papa ML, Salerno E, Mastrullo L, De Blasi D.
    Thromb Haemost; 1994 May; 71(5):544-7. PubMed ID: 8091377
    [Abstract] [Full Text] [Related]

  • 5. Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: a description of eleven patients treated.
    Scheibel E, Ingerslev J, Dalsgaard-Nielsen J, Stenbjerg S, Knudsen JB.
    Thromb Haemost; 1987 Dec 18; 58(4):1049-52. PubMed ID: 3127918
    [Abstract] [Full Text] [Related]

  • 6. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
    Ambriz Fernandez R, Quintana Gonzalez S, Martinez Murillo C, Dominguez Garcia V, Rodriguez Moyado H, Collazo Jaloma J.
    Arch Med Res; 1996 Dec 18; 27(1):15-8. PubMed ID: 8867361
    [Abstract] [Full Text] [Related]

  • 7. Factor VIII concentrate for hemophilia: comparison of two heat-treated products.
    Walker IR, Pai MK, Blair BA, Johnston MA, Birkett NJ, Ofosu FA, Naylor DH.
    CMAJ; 1987 Jan 15; 136(2):150-2. PubMed ID: 3098401
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A.
    Vlot AJ, Mauser-Bunschoten EP, Zarkova AG, Haan E, Kruitwagen CL, Sixma JJ, van den Berg HM.
    Thromb Haemost; 2000 Jan 15; 83(1):65-9. PubMed ID: 10669157
    [Abstract] [Full Text] [Related]

  • 13. [Clinical testing of Premofil M SRK, a blood coagulation factor VIII concentrate purified from human plasma using monoclonal an antibodies].
    Perret BA, Poorbeik M, Morell A.
    Schweiz Med Wochenschr; 1991 Nov 02; 121(44):1624-7. PubMed ID: 1947960
    [Abstract] [Full Text] [Related]

  • 14. Factor VIII half-life and clinical phenotype of severe hemophilia A.
    van Dijk K, van der Bom JG, Lenting PJ, de Groot PG, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, van den Berg HM.
    Haematologica; 2005 Apr 02; 90(4):494-8. PubMed ID: 15820945
    [Abstract] [Full Text] [Related]

  • 15. [Transient inhibitors developed in two cases of hemophilia A].
    Fujiwara F, Kanoh G, Ogawa H, Takaya K, Hibi S, Shima M, Yoshioka A, Imashuku S.
    Rinsho Ketsueki; 1997 Dec 02; 38(12):1263-8. PubMed ID: 9455145
    [Abstract] [Full Text] [Related]

  • 16. Factor VIII: C (FVIII: C) recovery and half-life after infusion of steam-treated high purity factor VIII concentrate in severe hemophilia A--comparison of one-stage assay, two-stage assay and a chromogenic substrate assay.
    Hellstern P, Kiehl R, Miyashita C, Schwerdt H, von Blohn G, Köhler M, Büttner M, Wenzel E.
    Thromb Haemost; 1986 Dec 15; 56(3):353-9. PubMed ID: 3105109
    [Abstract] [Full Text] [Related]

  • 17. The management of factor VIII inhibitors in non-hemophilic patients.
    Green D.
    Prog Clin Biol Res; 1984 Dec 15; 150():337-52. PubMed ID: 6431438
    [Abstract] [Full Text] [Related]

  • 18. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate.
    Peerlinck K, Arnout J, Di Giambattista M, Gilles JG, Laub R, Jacquemin M, Saint-Remy JM, Vermylen J.
    Thromb Haemost; 1997 Jan 15; 77(1):80-6. PubMed ID: 9031454
    [Abstract] [Full Text] [Related]

  • 19. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A.
    Rinsho Ketsueki; 1996 Nov 15; 37(11):1303-8. PubMed ID: 8960666
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.